Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy

paythelady.612 shared this article with you from Inoreader Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy Μέσω pubmed: "world j clin cases"... World J Clin Cases. 2021 Jul 16;9(20):5398-5407. doi: 10.12998/wjcc.v9.i20.5398. ABSTRACT While pancreatic cancer is still characterized by early systemic spread and poor outcomes, the treatment of this disease has changed significantly in recent years due to major advancements in systemic therapy and advanced surgical techniques. Broader use of effective neoadjuvant approaches combined with aggressive surgical operations within a multidisciplinary setting has improved outcomes. Borderline resectable pancreatic cancer is characterized by tumor vascular invasion, and is a setting where the combination of potent neoadjuvant chemotherapy and aggressive surgical methods, including vascular resections and reconstructions, shows its full potential. Hopefully, this will lead to improved local control and curative treatment in a number of patients with this aggressive malignancy. PMID:34307593 | PMC:PMC8281399 | DOI:10.12998/wjcc.v9.i20.5398 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.